Recent buying and selling of Thermo Fisher Scientific shares by several hedge funds and institutional investors include:
- Signature Resources Capital Management increased its holdings by 318.2%, now owning 46 shares worth $25,000.
- True Wealth Design boosted its stake by 1,275%, owning 55 shares valued at $29,000.
- New Millennium Group purchased a stake worth $29,000.
- Stephens Consulting raised their holdings by 116%, owning 54 shares worth $30,000.
- LifeSteps Financial acquired a stake valued at approximately $31,000.
Currently, 89.23% of the stock is held by institutional investors and hedge funds.
Wall Street Analyst Opinions
Several analysts provided reports on Thermo Fisher Scientific (TMO):
- Wells Fargo initiated coverage with an “overweight” rating and a $670 target.
- Royal Bank of Canada reiterated an “outperform” rating with a $767 target.
- Stifel Nicolaus raised their target to $680 with a “buy” rating.
- Evercore ISI increased their target to $630 with an “outperform” rating.
- TD Cowen set a target of $658 with a “buy” rating.
The consensus rating is “Moderate Buy” with a target of $653.72.
Read Our Latest Stock Report on TMO
Insider Trading Activity
In recent transactions, SVP Michael A. Boxer sold 2,000 shares at $600.85, totaling $1.2 million, leaving him with 13,083 shares valued at $7.9 million. EVP Gianluca Pettiti sold 300 shares for about $180,255. Insiders have sold a total of 23,084 shares worth $14.1 million in the last 90 days, holding 0.34% of the stock.
Stock Performance
Thermo Fisher shares opened at $600.92, with a market cap of $229.55 billion, a PE ratio of 38.55, and a 52-week low of $415.60, and a high of $627.88.
The latest quarterly earnings showed $5.37 EPS, exceeding the estimate of $5.13, with revenues at $10.54 billion.
Dividend Announcement
A quarterly dividend of $0.39 will be paid on October 15 to shareholders of record as of September 13. The annualized dividend amounts to $1.56, with a yield of 0.26%.
About Thermo Fisher Scientific
(Free Report)
Thermo Fisher Scientific provides life sciences solutions and a range of products and services worldwide, focusing on biological and medical research, pharmaceuticals, and diagnostics.
Read More
- Five stocks we like better than Thermo Fisher Scientific
- What does consumer price index measure?
- When Is the Best Time to Invest in Mutual Funds?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Is NVIDIA Stock in a Correction or Consolidation?
- How Technical Indicators Can Help You Find Oversold Stocks
- 3 Oversold Stocks with Big RSI Rebound Potential
Want to see what other hedge funds are holding TMO?
Visit HoldingsChannel.com for the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO Free Report).
Receive News & Ratings for Thermo Fisher Scientific Daily – Enter your email below to get a daily summary of the latest news and ratings with MarketBeat.com’s FREE daily email newsletter.
`
